Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)

Author： Kitagawa Yasuhide   Ueno Satoru   Izumi Kouji   Mizokami Atsushi   Hinotsu Shiro   Akaza Hideyuki   Namiki Mikio  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.140, Iss.4, 2014-04, pp. : 673-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer

By Hayat Roshanai Afsaneh   Nordin Karin   Berglund Gunilla  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1602-1608

Informa Healthcare

Access to resources Recommend Favorite

Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer

By Hanlon A.L.   Horwitz E.M.   Hanks G.E.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Value of PSA (Prostate-specific Antigen) in the Detection of Prostate Cancer in Patients with Urological Symptoms. Results of a Multicentre Study

By Cooperative Group for the Diagnosis of Prostate Cancer   Filella X.   Molina R.   Ballesta A.M.   Gil M.J.   Allepuz C.   Rioja L.A.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1125-1128

Elsevier

Access to resources Recommend Favorite

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

By                    

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 819-824

Spandidos Publications

Access to resources Recommend Favorite

Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite